Applied Materials (AMAT) Earnings Analysis

Applied Materials (AMAT) delivered mixed results in FY2026 on revenue of $136.1B versus the $136.9B estimate (-2.0% YoY) and EPS of $1.66. Below is the full Applied Materials earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Applied Materials (AMAT) Earnings Analysis — key stats

Next earnings dateJan 30, 2025
Latest reported quarterFY2026
Earnings verdictMixed
Revenue$136.1B (vs $136.9B est · -0.6% surprise · -2.0% YoY)
EPS$1.66 (vs $1.70 est · -2.4% surprise · +7.1% YoY)
Share price$106.86 (-1.8%)
Market cap$1.59T

What you'll find

Frequently asked questions

When is Applied Materials's next earnings date?
Applied Materials's (AMAT) next scheduled earnings date is Jan 30, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Applied Materials (AMAT) beat or miss earnings?
In FY2026, Applied Materials (AMAT) posted mixed results — revenue of $136.1B versus the $136.9B estimate (-0.6% surprise) and EPS of $1.66 versus $1.70 expected (-2.4% surprise). Magnisto decodes every Applied Materials (AMAT) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Applied Materials (AMAT) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Applied Materials (AMAT), anchored to the current $106.86 share price, so you can weigh the bull, base and bear cases for Applied Materials side by side.
Is Applied Materials (AMAT) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Applied Materials fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.